IVC earnings call for the period ending September 30, 2019.
News & Analysis: Invacare
IVC earnings call for the period ending March 31, 2019.
Investors hit the exits after Invacare's third-quarter earnings release. Here's why.
Shares jump after the company reports mixed quarterly results.
Invacare may be getting closer to resolving the FDA consent decree that's weighing down its results.
Invacare reported a smaller than expected loss and could be getting closer to resolving its FDA consent decree.
Invacare delivers market-topping results and draws strength from an unlikely region of the world, but can its share price continue to head even higher?
The company will again pay $0.0125 per share.
Just the facts, Fool.
Keep your eye on margins.